Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

A new protein was made to detect specific skin cell growth receptors and worked in normal skin but not in skin cancer cells.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

A woman with a rare hormone resistance condition also had missing teeth and hair loss, which might be new symptoms of her genetic disorder.

Propylthiouracil, a thyroid medication, can cause skin blood clots and immune-related blood vessel inflammation.

Antisense oligonucleotides show promise for treating Myotonic Dystrophy type I.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

Topical IKKα inhibitors may help prevent CCS tumours.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Activating β-catenin and inactivating PTEN cause follicular tumors, not papillomas, similar to those in Cowden’s Disease.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Thymic peptides can either promote or inhibit human hair growth.

Thiopurines help treat IBD but require genetic testing to avoid side effects.

Injecting monocyto-angiotropin into hare skin increases hair growth by forming new blood vessels.

Platelet-rich plasma helps treat hair loss, and better screening improves transfusion safety.

Blocking RANK signaling might help treat metastatic melanoma, but more research is needed.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

RTA 408 cream protects mice from radiation skin damage.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

KB2115 (eprotirome) can safely extend the hair growth phase without damaging cells or changing hair color.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

Dual TCR Treg cells are common in various mouse tissues and show diverse characteristics.

Higher thyroid antibodies in Hashimoto's thyroiditis are linked to more inflammation and symptoms.